Lv5
840 积分 2024-08-15 加入
Rational Design and Development of an Acyclic Chelator H4pyox for Theranostic Radiometal Labeling under Mild Conditions
10小时前
待确认
Preclinical Investigations to Explore the Difference between the Diastereomers [177Lu]Lu-SibuDAB and [177Lu]Lu-RibuDAB toward Prostate Cancer Therapy
13小时前
待确认
Preclinical and First-in-Human Study of Carbonic Anhydrase IX–Targeting Theranostic Pair, [ 68 Ga]Ga/[ 177 Lu]Lu-NYM096, in Clear Cell Renal Cell Carcinoma
13小时前
待确认
Preclinical Evaluation of68Ga/177Lu-Labeled FAP-Targeted Peptide for Tumor Radiopharmaceutical Imaging and Therapy
13天前
已完结
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
1个月前
已关闭
Clinical Implementation of Total-Body PET in China
2个月前
已完结
Beyond PSMA: theranostic cell surface targets in metastatic prostate cancer
2个月前
已完结
Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy
6个月前
已完结
Preclinical Evaluation of a Fibroblast Activation Protein and a Prostate-Specific Membrane Antigen Dual-Targeted Probe for Noninvasive Prostate Cancer Imaging
8个月前
已完结
Burden of cancer and changing cancer spectrum among older adults in China:Trends and projections to 2030
8个月前
已完结
皖公网安备34019202002308
